Strikingly, knockdown of RelB expression led to an even more pronounced cell death induced by Metformin treatment upon glucose starvation (Figure 4c), showing that RelB inhibition renders DLBCL MD901 cells highly susceptible to metabolic challenge. The gene discussed is RELB; the disease is diffuse large B-cell lymphoma.